Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

NCT02615106 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Endostar
RADIATION: 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine